首页|Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24

Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24

扫码查看
Immunodeficiency,centromeric instability,and facial anomalies(ICF)syndrome is a rare autosomal recessive disorder characterized by DNA hypomethylation and antibody deficiency.It is caused by mutations in DNMT3B,ZBTB24,CDCA7,or HELLS.While progress has been made in elucidating the roles of these genes in regulating DNA methylation,little is known about the pathogenesis of the life-threatening hypogammaglobulinemia phenotype.Here,we show that mice deficient in Zbtb24 in the hematopoietic lineage recapitulate the major clinical features of patients with ICF syndrome.Specifically,Vav-Cre-mediated ablation of Zbtb24 does not affect lymphocyte development but results in reduced plasma cells and low levels of IgM,IgG1,and IgA.Zbtb24-deficient mice are hyper and hypo-responsive to T-dependent and T-independent type 2 antigens,respectively,and marginal zone B-cell activation is impaired.Mechanistically,Zbtb24-deficient B cells show severe loss of DNA methylation in the promoter region of Il5ra(interleukin-5 receptor subunit alpha),and Il5ra derepression leads to elevated CD19 phosphorylation.Heterozygous disruption of Cd19 can revert the hypogammaglobulinemia phenotype of Zbtb24-deficient mice.Our results suggest the potential role of enhanced CD19 activity in immunodeficiency in ICF syndrome.

ICF syndromeZBTB24CD19IL-5Rahypogammaglobulinemia

Zhengzhou Ying、Swanand Hardikar、Joshua B.Plummer、Tewfik Hamidi、Bin Liu、Yueping Chen、Jianjun Shen、Yunxiang Mu、Kevin M.McBride、Taiping Chen

展开 >

Department of Epigenetics and Molecular Carcinogenesis,The University of Texas MD Anderson Cancer Center,Houston,TX 77030,USA

The Ministry of Education Key Laboratory of Laboratory Medical Diagnostics,College of Laboratory Medicine,Chongqing Medical University,Chongqing 400016,China

Program in Genetics and Epigenetics,The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences,Houston,TX 77030,USA

National Institutes of Health(NIH)National Institutes of Health(NIH)Core Facility Support Award from Cancer Prevention and Research Institute of Texas(CPRIT)nextgeneration sequencing(NGS)allowances from the Center for Cancer Epigenetics(CCE)at MD Anderson Cancer Centera fellowship from the Sam and Freda Davis Funda CCE Scholarship

1R01AI12140301A1CA16672RP170002

2023

中国免疫学杂志(英文版)
中国免疫学会

中国免疫学杂志(英文版)

CSTPCDCSCDSCI
影响因子:0.731
ISSN:1672-7681
年,卷(期):2023.20(12)
  • 69